Communiqués Mycotopia Therapies, Inc.

Actions

TPIA

US62846W1071

Temps Différé OTC Markets Autres places de cotation 18:29:56 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,03 ^USD	-25,00 %		-25,00 %	+87,50 %

15/05	Mycotopia Therapies, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/04	Mycotopia Therapies, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million	04/12	AQ
Mycotopia Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K	03/05/23	PU
MYCOTOPIA THERAPIES, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	03/05/23	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	30/03/23	AQ
MYCOTOPIA THERAPIES, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22/02/23	AQ
PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger	21/02/23	AQ
Ehave Shareholder from CEO Ben Kaplan and Corporate Update	07/12/22	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14/11/22	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	11/08/22	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23/05/22	AQ
Ehave Announces Mycotopia Therapies Reaches Definitive Agreement on Triangular Merger with Ei.Ventures to Form PSLY.com to List on NASDAQ	23/05/22	AQ
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction	20/05/22	PR
MYCOTOPIA THERAPIES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	19/05/22	AQ
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction	19/05/22	AQ
Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments	09/05/22	AQ
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market	02/05/22	AQ
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)	14/04/22	AQ
Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products	21/03/22	AQ
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.	17/03/22	AQ
MYCOTOPIA THERAPIES, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	14/01/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Mycotopia Therapies, Inc.

Actions

TPIA

US62846W1071

Communiqués

Filtres